Active Ingredient History
Hypromellose (INN), short for hydroxypropyl methylcellulose (HPMC), is a semisynthetic, inert, viscoelastic polymer used in eye drops, as well as an excipient and controlled-delivery component in oral medicaments, found in a variety of commercial products. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acanthamoeba Keratitis (Phase 2)
Cardiopulmonary Bypass (Phase 4)
Cataract (Phase 4)
Cesarean Section (Phase 2/Phase 3)
Conjunctivitis, Allergic (Phase 4)
Conjunctivitis, Viral (Phase 3)
Corneal Diseases (Phase 2)
Corneal Endothelial Cell Loss (Phase 2)
Dry Eye Syndromes (Phase 4)
Excipients ()
Fuchs' Endothelial Dystrophy (Phase 2)
General Surgery (Phase 2/Phase 3)
Glaucoma (Phase 4)
Graves Ophthalmopathy (Phase 2)
Irritable Bowel Syndrome (Phase 4)
Keratitis (Phase 4)
Lacrimal Duct Obstruction (Phase 3)
Macular Degeneration (Phase 2/Phase 3)
Obesity (Phase 4)
Periodontal Diseases (Phase 4)
Prostatic Neoplasms (Phase 2)
Sjogren's Syndrome (Phase 3)
Thyroid Neoplasms (Phase 3)
Wet Macular Degeneration (Phase 2/Phase 3)
Xerostomia (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
